Tolerability of Ramipril 10 mg/day in High-Risk Cardiovascular Chinese Patients

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.22, Iss.11, 2002-01, pp. : 771-781

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ramipril: A Review of its Use in Preventing Cardiovascular Outcomes in High-Risk Patients

By Anderson Vanessa R. Perry Caroline M. Robinson Dean M.

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 6, 2006-01 ,pp. : 417-432

Adis International

Access to resources Recommend Favorite

Ramipril cost effective in patients at high risk for cardiovascular events

Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Ramipril cost effective in patients at high risk for cardiovascular events

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 464, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Donepezil at Doses up to 20 mg/day: Results from a Pilot Study in Patients with Alzheimer's Disease

By Doody Rachelle S.

Drugs & Aging, Vol. 25, Iss. 2, 2008-01 ,pp. : 163-174

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of 24 Weeks of Therapy with Bendroflumethiazide 1.25 mg/day or 2.5 mg/day and Potassium Chloride Compared with Enalapril 10 mg/day and Amlodipine 5 mg/day in Patients with Mild to Moderate Primary Hypertension: A Multicentre, Randomised, Open Study

By Rasmussen S.

Clinical Drug Investigation, Vol. 26, Iss. 2, 2006-01 ,pp. : 91-101

Adis International

Access to resources Recommend Favorite